Anti-Infectives Have Blockbuster Future Despite Personalized Medicine
Executive Summary
Anti-infectives have the potential to remain top-selling products in the future even as personalized medicine curtails the number of therapies achieving blockbuster status, Lehman Brothers Vice Chairman Frederic Frank said